SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001564590-21-054257
Filing Date
2021-11-04
Accepted
2021-11-04 08:03:43
Documents
5
Effectiveness Date
2021-11-04

Document Format Files

Seq Description Document Type Size
1 LJPC-2021-11 S-8 POS REINCORPORATION NO. 333-214722 ljpc-s8pos.htm S-8 POS 144164
2 EX-5.1 ljpc-ex51_6.htm EX-5.1 8765
3 EX-23.1 ljpc-ex231_7.htm EX-23.1 3940
4 GRAPHIC gxojbrd1j5hw000002.jpg GRAPHIC 30438
5 GRAPHIC gxojbrd1j5hw000001.jpg GRAPHIC 89690
  Complete submission text file 0001564590-21-054257.txt   323507
Mailing Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451
Business Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 617-715-3600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-214722 | Film No.: 211378104
SIC: 2836 Biological Products, (No Diagnostic Substances)